|
|||||
|
|
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit |
|
| Affiliation: | 1. Department of Medicine, Cedars-Sinai Cancer, Los Angeles, CA 90048, USA;2. School of Life Sciences & Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh 208024, India;3. Department of Surgery, Cedars-Sinai Cancer, Los Angeles, CA 90048, USA;4. VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA |
| Abstract: |  |
| Keywords: | PCa androgen receptor splice variants CD105 cancer-associated fibroblasts endoglin |
| 本文献已被 ScienceDirect 等数据库收录！ | |
